~~<i id='316F5013B0'><strike id='316F5013B0'><tt id='316F5013B0'><pre id='316F5013B0'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

author：knowledge 2025-09-30 06:18:40 Page View：93

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Is there really a nursing shortage in the U.S.?
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

Alabama frozen embryo ruling has major implications for IVF clinics

ContainersholdingfrozenembryosandspermarestoredinliquidnitrogenatafertilityclinicinFortMyers,Fla.Lyn

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Community Health Systems hospitals under DOJ investigation

BRENDANSMIALOWSKI/AFPviaGettyImagesCommunityHealthSystemsisfacinganewfederalprobeintoitshospitalbill

WSS

hotspot

hotspot

focus

knowledge

Community Health Systems hospitals under DOJ investigation